The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

RTALB FINANCIAL STATEMENTS

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. — balance sheet, income statement and cash flow trends

RTALBRTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.

🇹🇷 Turkey · IS · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0500 M1 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue315.3 M ₺Gross Profit85.5 M ₺ · 27%Operating Income-21.8 M ₺ · -7%Pre-tax Income334.4 M ₺ · 106%Net Income to Owners48.7 M ₺ · 15%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue315.3 M ₺+24.2%
Gross Profit85.5 M ₺+1.8%
Operating Income-21.8 M ₺—
EBITDA-1.8 M ₺—
Net Income to Owners48.7 M ₺-85.3%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
02 B4 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets3.3 B
  • Equity2.9 B ₺89%
  • Current Liabilities59.8 M ₺2%
  • Long-term Liabilities301.5 M ₺9%

Key Figures

YoY change
Total Assets3.3 B ₺+47.5%
Total Liabilities361.4 M ₺+249.1%
Total Equity2.9 B ₺+37.6%
Cash & ST Investments81.1 M ₺+745.6%
Total Debt21.9 M ₺-67.2%
Net Debt-52.7 M ₺-185.1%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M0200 M400 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
050 M100 M150 M25.7 M ₺Operating153.4 M ₺Investing-109.2 M ₺Financing69.9 M ₺Net Change

Key Figures

YoY change
Operating Cash Flow25.7 M ₺—
Capital Expenditures-30.8 M ₺—
Free Cash Flow179 M ₺+42.6%
Dividends Paid0 ₺—

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on RTALB

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.